Distinguished in Attention Deficit Hyperactivity Disorder (ADHD)

Ridha Joober

6875 LaSalle Boulevard, H4H 1R3, 
Montreal, QC, CA 
Distinguished in Attention Deficit Hyperactivity Disorder (ADHD)
6875 LaSalle Boulevard, H4H 1R3, 
Montreal, QC, CA 
OverviewLocationsClinical Research

Overview

Ridha Joober practices in Montreal, Canada. Joober is rated as a Distinguished expert by MediFind in the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Their top areas of expertise are Schizophrenia, Attention Deficit Hyperactivity Disorder (ADHD), Congenital Mirror Movement Disorder, and Anorexia.

Their clinical research consists of co-authoring 317 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 52 articles and participated in 1 clinical trial in the study of Attention Deficit Hyperactivity Disorder (ADHD).

Locations

6875 LaSalle Boulevard, H4H 1R3, Montreal, QC, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Manualized Group Cognitive-behavioral Therapy for Social Anxiety in First Episode Psychosis: A Randomized Controlled Trial
Manualized Group Cognitive-behavioral Therapy for Social Anxiety in First Episode Psychosis: A Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: October 25, 2022
Intervention Type: Behavioral
Study Phase: Not Applicable
Efficacy of Careful Medication and Tailored Case Management Follow up Treatment for Children With Attention Deficit Hyperactivity Disorder
Efficacy of Careful Medication and Tailored Case Management Follow up Treatment for Children With Attention Deficit Hyperactivity Disorder
Enrollment Status: Unknown
Publish Date: August 28, 2018
Intervention Type: Drug, Behavioral
Study Phase: Not Applicable
View 1 Less Clinical Trial

317 Total Publications

The manicogenic properties of clozapine: a rare but serious potential adverse effect.
The manicogenic properties of clozapine: a rare but serious potential adverse effect.
Journal: Journal of psychiatry & neuroscience : JPN
Published: May 27, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Joober's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile